A growing number of women are seeking treatments aimed at improving intimate health and addressing conditions often overlooked or misdiagnosed within mainstream healthcare. At the forefront of this movement is Dr. Lakhani, a practitioner specializing in female intimate health who operates a private clinic offering advanced therapeutic procedures designed to enhance both comfort and sexual wellbeing.
Dr. Lakhani gained public attention following a 2024 television appearance demonstrating the Ultra Femme 360, a vaginal radiofrequency treatment marketed for tightening and rejuvenation. Despite initial media sensationalism, the exposure led to increased inquiries from women who found the treatments offered solutions to previously unresolved issues. Many patients come to the clinic after experiencing dismissal or misdiagnosis in conventional settings, particularly those suffering from lichen sclerosus, a painful inflammatory condition primarily affecting genital tissue. In severe cases, lichen sclerosus can cause scarring and fusion of the labia and clitoris. Dr. Lakhani has conducted an observational study involving 24 patients treated with the Morpheus8V device—a combination of microneedling and radiofrequency intended to stimulate collagen and elastin production—with promising results that support further clinical trials.
During consultations, patients also receive personalized guidance on pelvic floor health. Many arrive having incorrectly performed pelvic floor exercises; treatments such as the VTone device provide electrical muscle stimulation to strengthen this area. Another procedure frequently offered is the “O Shot,” an injection of platelet-rich plasma derived from the patient’s blood aimed at improving sexual function by promoting tissue regeneration.
Combined, these procedures can be costly, with a single Morpheus8V session priced around £1,000, the O Shot approximately £1,500, and VTone sessions typically starting at £300 each. Clinicians generally recommend multiple sessions for optimal effect, which may put these treatments out of reach for many. Home-use devices that claim similar benefits and are more affordable have also gained popularity, though their effectiveness varies.
While the sector is expanding rapidly, concerns have been raised about safety and regulation. An accreditation body specializing in aesthetic procedures reports a rise in complaints related to intimate treatments—from 16 in 2021 to 136 in the current year—many linked to interventions performed by inadequately trained practitioners. Cases cited include internal burns from radiofrequency devices and severe infections following labial filler injections conducted in unregulated settings such as salons.
Efforts to tighten regulation have been proposed, with the government in 2025 outlining plans to reclassify genital injectable treatments as requiring medical oversight. However, legal implementation remains pending, leaving women vulnerable to potentially harmful procedures outside professional medical environments.
Advocates emphasize the importance of recognizing sexual health as an integral component of overall health, cautioning that while the pursuit of aesthetic enhancements carries risks, addressing genuine medical and functional concerns deserves attention and professional care.